OPRM1 and Pruritus: Naltrexone, an orally semisynthetic MOR antagonist, was demonstrated to be effective in suppressing pruritus in patients with CTCL [216, 248–250], and another MOR antagonist, naloxone, improved pruritus in a patient with MF [251].